StockData
Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc. (MIRM) stock

MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30
$92.49+0.54 (+0.59%)

Close on Nov 18, 2026Market cap $6.01BP/E –Yield –

Mirum Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Mirum Pharmaceuticals

Mirum Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Mirum Pharmaceuticals figures

See a number that looks wrong?